Unijules Annual Report 2009 by Unijules Life Sciences Ltd

A N 2 N 0 U 0 8 A L 2 0 R 0 E 9 P

2 0 0 8 2 0 0 9

A N N U A L R E P O R T A N D A C C O U N T S

UNIJULES LIFE SCIENCES LIMITIED DIRECTORS REPORT To, The Members, The Directors of your Company have pleasure in presenting their Fourth annual report together with the audited Balance Sheet as on 31st March 2009, the Profit and Loss Account for the year ended on 31st March 2009 and the Auditors Report thereon. Performance In continuation of last year performance, 2008-09 turned out to be as per expectation. The Intellectual property developed and commercialized for the 1st time last year reaped in wonderful results strengthening the business plan and balance sheet further. This assumes great importance in these critical times and will be of great benefit in helping the company through this period. All the CAPEX initiated last year in terms of Modernization at the parenteral unit and certification of new unit at B 34 Kalmeshwar was satisfactorily completed and will be running to optimum efficiency during 09-10. This will be vital as the process of converting the company out sourcing activities to own manufacturing thus improving margins considerable even at a lower turnover. On the HRD front, professionals have come on board in critical areas like Quality Assurance and Engineering departments in anticipation of large volume and high speed manufacturing for optimal capacity utilization. On the marketing front, independent business divisions resulted in an even growth in all segments further fortifying future revenue streams. On the corporate front, great relations backed by solid performance resulted in smooth funding and induction of nationalized bank like SBI with commitment of funding for CAPEX planned through 09 up to 11 for both the herbals and parenteral projects. Going forward, your company expects to repeat the same performance based on the positives achieved in 08-09 in terms of capacity expansion, new manpower and existing relationships with large companies from where bulk of the business is expected for technology products like herbal pellets, narcotics formulations and contrast media.

The financial highlights for the previous year are given here below: Financial Results (Rs. In Millions)

2,000.00

2006-07 1,637.90

1,500.00

2007-08 2008-09

1,150.87

1,000.00 500.00

370.90 153.27 205.70 30.40

15.36

78.77 81.18

0.00 Net Sales

EBIDTA

PAT

700 600 500

2006-07

633.07

2007-08 429.19

2008-09

400 328.63 300 200

169.21 145.69 34.51

100 0 Book Value Per Share 1,000.00

EPS

933.65

2006-07 2007-08

800.00 602.41

2008-09

600.00 426.55 238.63

400.00 299.34

146.24

200.00 0.00 Total Assets

Networth

3.35

350.00%

2006-07

300.00%

2007-08

250.00%

1.99

200.00%

2008-09 1.64

150.00% 100.00% 50.00% 0.00%

34.51%

8.18%13.26% 12.44% EBDITA to Op. Income %

141.60% 121.21%

Debt / Equity Ratio Times

PAT / Equity Ratio %

10.15% 25.44% 21.97% EBIDTA / Total Fund %

Year in Retrospect: The company has repeated its winning streak of clocking 42.90% incremental growth in the last year's. The Company has achieved a total sale of Rs 1637.90 Millions (net of excise) as against Rs 1150.86 Millions (net of excise) for the same period in the last year. The Company has achieved a net profit of Rs 135.16 Million (before provision of tax) as against Rs 114.87 Millions for the same period in the last year registering an increase of 17.66%.

Business Outlook: â&#x20AC;˘ All manufacturing locations of the group were corporatized as profit center which yielded great results in terms of efficiencies, cost cutting and independent business development. The management expects this to be of great advantage in collective growth in the new fiscal. â&#x20AC;˘ ? ?

Expanded capacities combined with reduced tariffs have made the company very attractive for local marketing entities and also 3rd party exporters. The management expects substantial growth in this area of operations. The scope and penetration of REVAYUR beauty care range received a big boost due to partnership with BIG BAZAR chain of super stores, the largest in India. New products introduced during this fiscal will help the company achieve better numbers and visibility. Registration of 13 herbal pellet products in Malaysia through CCM Corporation was a major success of last year out of which 6 products were successfully manufactured and supplied. The company expects partnership to be of great importance in terms of business and synergies during the new fiscal from the entire ASEAN market. Aggressive work on domestic marketing in last year resulted in substantial growth in sales and per PSR productivity. Gross margins increased substantially by way of new value added products launched in the market place. Major growth in top line expected from this segment going forward. Future growth drivers include launch of local herbal pellet products as a brand extension of the already well established REVAYUR brand name, major thrust towards institutional business taking advantage of huge budgets being allocated to social health care, expansion of market reach in contrast media products and penetration in the African tender business.

DIVIDENDS During the period under review the directors are unable to recommend any dividend on the equity shares of the company.

Fixed Deposit During the year under review the company has not accepted any deposit.

Directors Mr. Anwar Daud and D.K. Bellani directors, retire by rotation under article 103 of the articles of association of the company and being eligible, offer him for reappointment

Industrial Relation Industrial relation continues to be cordial. Your directors express deep appreciation for the dedicated services rendered by workers, staff officers of the company.

Auditors The Company's auditors M/s Ali Hatim S. Husain, Chartered Accountants, retire at this Annual General Meeting and being eligible offer themselves for reappointment. The notes to the accounts referred to in the Auditor's Report are self-explanatory and, therefore do not call for any further comments.

Subsidiaries As of 31st March, 2009, the Company had one Subsidiary viz. Zim Laboratories Limited Statement pursuant to section 212 of the Companies Act, 1956, related to Subsidiary Company attached separately.

Particulars of employees None of the employee is in receipt of remuneration in excess of the limits prescribed under section 217(2A) of the Companies Act, 1956 read with the Companies (Particulars if Employees) Rules, 1975.

Directors' Responsibility Statement Pursuant to sub-section (2AA) of section 217 of the Companies Act 1956, the Board of Directors of the Company hereby state and confirm that: I. In the preparation of the Annual Accounts, the applicable accounting standards, to the extent applicable, have been followed along with proper explanation relating to material departures. II. The Directors has selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company as at 31.03.2009 and of the profit of the company for the period ended on that date. III. The Directors has taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act 1956 for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities. IV. The Directors had prepared the annual accounts on a going concern basis.

Information required under section 217(1) (E) of Companies Act. Conversation of energy In the opinion of the directors there is no need to take any measure in this regard. The company does not have any proposal for additional investment in this regard. The details of energy consumption are not required to be given.

Technology absorption The research and experiments are carried on as part of the normal business activities as such no separate figures are available.

Acknowledgment Directors wish to express their grateful thanks to the Government of India and the Company's Banker namely Axis Bank Ltd., Mumbai, Shamrao Vithal Co-operative Bank Ltd. And the State Bank of India. Nagpur. Our directors wish to thank the customers and suppliers and place on record their appreciation for the services rendered by the employees of the company.

Faiz Vali CEO

Al i Hat im S. Husain Chartered Accountant AUDITORâ&#x20AC;&#x2122;S REPORT To the members of UNIJULES LIFE SCIENCES LIMITED We have audited the attached Balance Sheet of Unijules Life Sciences Limited as at 31st March 2009, the Profit and Loss Account and also the Cash flow statement for the year ended on that date annexed thereto. These financial statements are the responsibility of the company's management. Our responsibility is to express an opinion on these financial statements based on our audit. 1. We conducted our audit in accordance with auditing standards generally accepted in India.Those Standards require that we plan and perform the audit to obtain reasonable assuranceabout whether the financial statements are free of material misstatement. An audit includesexamining, on a test basis, evidence supporting the amounts and disclosures in the financialstatements. An audit also includes assessing the accounting principles used and significantestimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion. 2. As required by the Companies (Auditor's Report) Order, 2003 issued by the Central Government of India in terms of sub-section (4A) of section 227 of the Companies Act, 1956, we enclose in the Annexure, a statement on the matters specified in paragraphs 4 and 5 of the said order. 3. Further to our comments in the Annexure referred to in paragraph 2 above, we report that: a) We have obtained all the information and explanations, which to the best of our knowledge and belief were necessary for the purpose of our audit. b) In our opinion, proper books of account, as required by the law, have been kept by the company, so far as appears from our examination of those books. c) The Balance Sheet, the Profit & Loss Account and the cash flow statement dealt with by this report are in agreement with the books of account. d) In our opinion, the Balance Sheet, the Profit & Loss Account and the cash flow statement dealt with by this report comply with the mandatory Accounting Standards referred to in sub-section (3C) of section 211 of the Companies Act 1956 e) In our opinion, and based on information and explanation given to us, none of Directors are disqualified as on 31st March 2009 from being appointed as Directors in term of section 274(1)(g) of The Companies Act, 1956. f) In our opinion and to the best of our information and according to the explanations given to us, the said accounts read together with the significant Accounting Policies and other notes thereon give the information required by the Companies Act, 1956, in the manner so required, and present a true and fair view in conformity with the accounting principles generally accepted in India: (i) In so far as it is relates to Balance Sheet, of the state of affairs of the company as at 31st March 2009; (ii) In so far as it relates to the Profit & Loss Account, the profit of the company for the year ended on that date; and (iii) In so far as it relates to the cash flow statement, of the cash flow of the company for the year ended on that date. Ali Hatim S. Husain Memo No. 113999 Place:- Nagpur Date: - 12th June 2009

ANNEXURE REFERRED TO IN PARAGRAPH 2 OF THE AUDITOR'S REPORT ON THE ACCOUNTS OF UNIJULES LIFE SCIENCES LIMTED FOR THE YEAR ENDING 31ST MARCH 2009 As required by the Companies (Auditor's report) Order, 2003 issued by the central Government of India in terms of section 227(4-A) of the Companies Act, 1956, we report that: 1 In respect of fixed assets: (A) The company has maintained proper records showing full particulars, including quantitative details and situation of fixed assets on the basis of ` available information. (B) As explained to us, all the fixed assets have been physically verified by the management during the year at reasonable intervals, which in our pinion, is reasonable having regard to the size of the company and the nature of assets. No material discrepancies were noticed on such physical verification. (C) In our opinion the Company has not disposed off any substantial/major part of fixed assets during the year and the going concern status of the ] company is not affected. 2 In respect of its inventories: (A) As explained to us, the inventory has been physically verified by the management at regular intervals during the year. (B) In our opinion and according to the information and explanations given to us and on the basis of our examination of the records of inventory, the Company has maintained proper records of inventory. And there were no material discrepancies noticed on physical verification of inventory as compared to the book records. 3 In respect of loans, secured or unsecured, granted or taken by the company to/from companies, firms or other parties covered in the register maintained under section 301 of the Companies Act 1956: (A) The company has granted Loans to three parties. At the year end the outstanding balance of such loans granted was Rs.217.36 Lacs and the maximum amount involved during the year was Rs.296.24 Lacs. (B) In our opinion and according to the information and explanations given to us, the rate of interest, wherever applicable and other the terms and conditions are not prima-facie prejudicial to the interest of the company. (C) In respect of loans taken and granted by the company, the interest payment & receipt is regular and the principal amount is repayable on demand. (D) Since the loans taken and granted by the company are repayable on demand, no question of overdue amounts arises. 4 In our opinion and according to the information and explanations given to us, there are adequate internal control procedure commensurate with the size of the company and nature of its business with regard to purchase of inventory and fixed assets and with regard for the sale of goods and services. During the course of audit, no major weakness has been noticed in the internal control. 5 In respect of contracts or arrangements entered in the register maintained in pursuance of Section 301 of the Companies Act, 1956. (A) In our opinion and according to the information and explanation given to us, the transactions made in pursuance of contracts or arrangements, that needed to be entered in the register maintained under section 301 of the Companies Act 1956 have been so entered. (B) In our opinion and explanation given to us, the transactions exceeding the value of 5 lakh in respect of any party during the year have been made at prices which are prima-facie reasonable having regard to prevailing market prices at the relevant time where such prices are available. 6 In our opinion and according to the information and explanations given to us, the Company has not accepted deposits from the public and therefore, the provisions of Section 58A and 58AA of the Companies Act, 1956 and Rules made there under are not applicable to the Company. 7 In our opinion, the company has an internal audit system commensurate with its size and nature of its business. 8 To the best of our knowledge the Central Government has not prescribed the maintenance of cost records U/s 209(1) (d) of the company act, 1956 for any of the products of the company. 9 In respect of statutory dues: (A) According to the information and explanations given to us, the company was generally regular in depositing dues in respect of Employees Provident Fund, Employees State Insurance Fund, Income Tax, and other statutory dues with the appropriate authority during the year. (B) According to the records examined by us and the information and explanations given to us, there are no disputed amounts due in respect of income tax, wealth tax, sales tax, excise duty, Employees provident fund, Employee state insurance fund and other statutory dues at the end of the year. 10 The Company does not have accumulated losses as at the end of the year and the Company has not incurred cash losses during current and the immediately preceding financial year.

11 Based on our audit procedures and on the basis of information and explanations given by the management, the Company has not defaulted in the repayment of dues to banks, financial institutions and Debentures holders during the year. 12 In our opinion and according to information and explanation given to us, no loans and advances have been granted by the company on the basis of security by way of pledge of shares, debentures and other security. 13 In our opinion the company is not a Chit Fund, Nidhi or Mutual Benefit Fund/Society. Therefore, the provisions of clause 4(XIII) of the CARO,2003 are not applicable to the company. 14 The company is not dealing in or trading in shares, securities, debentures and other investments. Accordingly, the provisions of clause 4(xiv) of the order are not applicable. 15 The Company has given Guarantees for the loan taken by others from banks or financial institutions. In our opinion, the terms and conditions on which the company has given guarantees for the loan taken by others from banks or financial institution are not prima-facie prejudicial to the interest of the company 16 In our opinion, the term loans have been applied for the purpose for which they were raised. 17 According to the information and explanations given to us and on examination of balance sheet, funds raised on short term basis have, prima facie, not been used during the year for long term investment and vice versa. 18 The company has made preferential allotment to parties and companies covered under register maintained under Section 301 of the Companies Act, 1956, during the year. The price at which the shares have been issued is not prejudicial to the interest of the Company. 19 The Clause 13 of the order is not applicable, as the company has not issued any debentures during the year. 20 The Company has not raised money by any public issues during the year and hence the question of disclosure and verification of end use of such money does not arise. 21 In our opinion and according to the information and explanations given to us no fraud on or by the Company has been noticed or reported during the year that causes the financial statements to be materially misstated.

Ali Hatim S. Husain Memo No. 113999 Place:- Nagpur Date: - 12th June 2009

UNIJULES LIFE SCIENCES LIMITED, MUMBAI BALANCE SHEET AS AT 31st. MARCH, 2009 SCHEDULE

31-03-2009

31-3-2008

(Rs)

SOURCES OF FUNDS: 1. SHAREHOLDERS' FUND : Share Capital

"A"

6,69,74,500.00

5,56,27,500.00

Reserve & Surplus

"B"

35,48,33,031.10

18,30,01,308.22

Share Application Money

47,40,000.00

42,65,47,531.10 2.DEFERRED TAX LIABILITIES

23,86,28,808.22

2,19,34,254.33

3. LOAN FUNDS : Secured Loans

"C"

48,75,29,720.92

33,90,40,295.35

Unsecured Loans

"D"

3,37,805.00

2,47,39,986.00

48,78,67,525.92

36,37,80,281.35

93,63,49,311.35

60,24,09,089.57

25,73,12,615.71

21,41,98,485.32

1,49,47,850.72

59,67,233.15

24,23,64,764.99

20,82,31,252.17

Total APPLICATION OF FUNDS : 1. FIXED ASSESTS : (At Cost)

"E"

Gross Block Less: Depreciation Net Block Capital Work in Progress

24,23,64,764.99

20,82,31,252.17

3,06,15,900.00

5,11,75,900.00

3,06,15,900.00

5,11,75,900.00

a) Inventories

19,14,28,194.38

17,45,04,760.29

b) Sundry Debtors

52,45,16,082.93

44,80,13,051.48

1,24,04,171.28

6,92,98,303.01

13,92,16,597.21

8,32,09,002.45

86,75,65,045.80

77,50,25,117.23

2. INVESTMENTS :

"F"

3. CURRENT ASSESTS, LOANS & ADVANCES : "G"

c) Cash & Bank Balances

d) Loans & Advances

Less: CURRENT LIABILITIES & PROVISIONS:

4. MISCELLANEOUS

"H"

EXPENDITURE

(To the extent not written - Off)

20,67,47,400.82

43,57,53,160.40

66,08,17,644.98

33,92,71,956.83

25,51,001.38

37,29,980.57

25,51,001.38

37,29,980.57

93,63,49,311.35

60,24,09,089.57

"I"

Total : ACCOUNTING POLICIES, CONTINGENT LIABILITIES AND NOTES :

"J"

Schedule "A" to "I" referred to above form an integral part of the Balance Sheet. As per our report of even date.

Ali Hatim S. Husain (Chartered Accountant) Membership No. 113999 Nagpur Dated the, 12th June 2009

Faiz Vali

D. K. Bellani

(Chief Executive Officer)

(Chief Production Officer)

UNIJULES LIFE SCIENCES LIMITED, MUMBAI PROFIT AND LOSS ACCOUNT FOR THE YEAR ENDING 31ST MARCH, 2009 SCHEDULE

2008-09

2007-08

(Rs)

INCOME : Sales

"1"

1,64,46,11,734.73

1,15,98,98,348.59

67,07,023.00

90,33,704.00

1,63,79,04,711.73

1,15,08,64,644.59

95,43,051.50

55,91,936.46

1,64,74,47,763.23

1,15,64,56,581.05

Less : - Excise Duty Net Sales Other Income

"2" Total

EXPENDITURE : Cost of Materials

"3"

1,28,92,90,866.86

90,28,17,549.24

Manufacturing Expenses

"4"

2,16,00,061.75

1,11,20,680.86

Employees Remuneration & Benefits

"5"

3,54,10,204.04

2,80,52,725.82

Other Expenses

"6"

9,54,50,227.64

6,12,00,199.39

Financial Expenses

"7"

6,01,33,071.00

3,20,75,964.00

91,84,073.54

50,97,200.48

1,23,916.00

10,95,070.19

1,51,22,87,491.02

1,04,15,83,305.98

13,51,60,272.21

11,48,73,275.07

11,98,526.00

5,02,753.00

2,48,769.00

(1,095.00)

Deferred Tax Liabilities

2,19,34,254.33

Income Tax

3,00,00,000.00

3,50,00,000.00

6,00,000.00

Profit after tax

8,11,78,722.88

7,87,71,617.07

Profit Brought forward from previous year

9,41,28,808.22

1,53,57,191.15

17,53,07,531.10

9,41,28,808.22

145.69

169.21

Depreciation Preliminary Expenses W.off Deferred Revenue Expenses W.off Total Profit before tax Tax for the earlier Year: Income Tax Fringe Benefit Tax Tax for the year : -

Fringe Benefit Tax

Profit Carried over to Balance Sheet Earning Per Share Basic EPS & Diluted Earning Per shares

Schedule "1" to "7" referred to above form an integral part of the profit and loss account. As per Our report of even date Ali Hatim S. Husain Chartered Accountant

Faiz Vali

D. K. Bellani

Membership No. 113999

(Chief Executive Officer)

(Chief Production Officer)

Nagpur Dated the, 12th June 2009

UNIJULES LIFE SCIENCES LIMITED, MUMBAI SCHEDULES FORMING PART OF BALANCE SHEET AS AT 31st. MARCH, 2009 31-03-2009

31-3-2008

(Rs)

SCHEDULE "A" SHARE CAPITAL : AUTHORISED : 15,00,000 Equity Shares of Rs. 100/- each (Previous Year 15,00,000)

15,00,00,000.00

6,69,74,500.00

5,56,27,500.00

6,69,74,500.00

5,56,27,500.00

Share Premium Reserve

17,95,25,500.00

8,88,72,500.00

Profit and Loss Account

17,53,07,531.10

9,41,28,808.22

35,48,33,031.10

18,30,01,308.22

Total ISSUSED, SUBSCRIBED AND PAID UP : 6,69,745 Equity Shares of Rs. 100/- each fully called up and paid up in cash (Previous year 5,56,275) Total SCHEDULE "B" RESERVE & SURPLUS

Total SCHEDULE "C" SECURED LOANS :

FROM BANK: (THE SHAMRAO VITHAL CO-OP BANK LTD) Cash Credit Account:

12,62,21,988.63

7,04,36,524.10

1,06,61,876.00

2,95,83,830.00

5,13,455.25

(Against Hypothecation of Raw and Packing Material, Work-in-process, Finished Goods and Book - Debts) Term Loans: I (Against Mortgage of Shantinagar Assets) (Repayable within one year Rs.106.62 Lacs) III (Against Plant and Machienry at Kalmeshwar) (Repayable within one year Rs. Nil Lacs)

II (Against Mortgage of D- 82 Hingna Assets)

2,90,85,572.00

3,65,94,166.00

17,17,27,836.29

14,89,61,153.00

2,79,23,912.00

5,00,00,000.00

10,04,34,983.00

2,03,31,555.00

26,80,484.00

11,41,998.00

2,70,683.00

48,75,29,720.92

33,90,40,295.35

(Repayable within one year Rs. 87.03Lacs) FROM BANK: (THE AXIS BANK LTD) Cash Credit Account: (Against Hypothecation of Raw and Packing Material, Work-in-process, Finished Goods and Book - Debts)

Term Loans: I (Against Mortgage of Fixed Assets) (Repayable within one year Rs. 99.96 Lacs) FROM BANK: (STATE BANK OF INDIA) Cash Credit Account: (Against Hypothecation of Raw and Packing Material, Work-in-process, Finished Goods and Book - Debts)

Term Loans: I (Against Mortgage of Fixed Assets) (Repayable within one year Rs.68.57 Lacs) NATIONAL SMALL INDUSTRIES CORPORATION (Against Bank Guarantee) From Finance Companies (Under Hire Purchase Agreement) Total SCHEDULE "D" UNSECURED LOANS : From Directors

From Coporate Bodies

2,36,00,756.00

3,37,805.00

11,39,230.00

3,37,805.00

2,47,39,986.00

From Others Total

Wadi Land & Godown

Lease Hold Plot (B 35) Kalmeshwar

Factory Building (Kalmeshwar)

Factory Building (Hingna)

Factory Building (Herbal)

Plant & Machinery (Hingna)

Plant & Machinery (Kalmeshwar)

Plant & Machinery (Herbal)

Air Handling Unit (Hingna)

Electric Installation (Kalmeshwar)

Electric Installation (Herbal)

Laboratory Equuipment (Hingna)

Laboratory Equuipment (Kalmeshwar)

Laboratory Equuipment (Shantinagar)

Laboratory Equipment (Herbal)

Laboratory Equipment

Electric Installation (Hingna)

Electric Installation

Air Handling Unit (Kalmeshwar)

AHU

Plant & Machinery (Shantinagar)

Plant & Machinery

Factory Building (Shantinagar)

Factory Building

Lease Hold Plot (D - 82 Hingna)

Freehold Land

45,04,439.99

34,42,397.39

50,90,579.58

3,24,889.00

32,18,947.06

78,62,732.83

3,02,59,079.50

78,58,045.07

1,25,07,047.30

98,41,214.50

6,72,95,419.72

3,99,02,626.58

41,95,023.00

26,60,175.09

49,88,569.87

01.04.2008

NO.

PARTICULARS

As on

SR.

As at 31st March 2009

Statement of Fixed Assets

SCHEDULE "E"

UNIJULES LIFE SCIENCES LIMITED

15,500.00

30,40,714.00

20,81,989.34

57,09,152.00

12,427.00

3,41,159.50

3,85,731.00

28,83,019.00

29,55,688.50

96,473.78

31,83,715.62

23,94,036.00

22,90,151.00

8,11,052.65

65,50,073.50

70,33,250.94

Year

during the

2,78,795.00

21,39,505.00

Deduct.

Sales /

GROSS BLOCK Additions

15,500.00

30,40,714.00

65,86,429.33

91,51,549.39

12,427.00

54,31,739.08

7,10,620.00

61,01,966.06

1,05,39,626.33

96,473.78

3,13,03,290.12

1,02,52,081.07

1,47,97,198.30

8,11,052.65

1,63,91,288.00

7,43,28,670.66

3,99,02,626.58

41,95,023.00

26,60,175.09

49,88,569.87

31.03.2009

As on

1,13,199.89

1,95,703.32

1,89,639.39

23,088.78

2,03,866.65

2,01,131.39

9,79,448.74

4,61,852.42

7,31,738.06

3,86,660.33

6,243.52

16,65,934.66

31.03.2008

Upto

314.67

73,884.84

2,41,475.06

4,56,090.45

236.26

2,54,295.51

17,306.96

1,56,719.29

4,63,318.77

2,449.98

14,34,320.53

4,11,674.42

6,04,796.29

360.20

3,29,689.59

22,51,003.20

13,34,343.83

Addition

Year

1,19,332.27

Subtraction

Year

During the

DEPRECIATION During the

314.67

73,884.84

3,54,674.95

6,51,793.77

236.26

4,43,934.90

40,395.74

3,60,585.94

6,64,450.16

2,449.98

24,13,769.27

8,73,526.84

13,36,534.35

360.20

7,16,349.92

22,57,246.72

28,80,946.22

31.03.2009

Total as on

15,185.33

29,66,829.16

62,31,754.38

84,99,755.62

12,190.74

49,87,804.18

6,70,224.26

57,41,380.12

98,75,176.17

94,023.80

2,88,89,520.85

93,78,554.23

1,34,60,663.95

8,10,692.45

1,56,74,938.08

7,20,71,423.94

3,70,21,680.36

41,95,023.00

26,60,175.09

49,88,569.87

As on

43,91,240.10

32,46,694.07

49,00,940.19

3,01,800.22

30,15,080.41

76,61,601.44

2,92,79,630.76

73,96,192.65

1,17,75,309.24

94,54,554.17

6,72,89,176.20

3,82,36,691.92

41,95,023.00

26,60,175.09

49,88,569.87

31.03.2008

NET BLOCK 31.03.2009

As on

Office Equipments (Kalmeshwar)

Office Equipment (Injectable Division)

Compt & Access (Hingna)

Compt & Access (Kalmeshwar)

Compt & Access (Herbal Division)

E.P.A.B.X. (Kalmeshwar)

E.P.A.B.X. (Herbal)

Vehicles (Kalmeshwar)

Vehicles (Hingna)

Furniture & Fixture (Hingna)

Furntiure & Fixture (Kalmeshwar)

Furntiure & Fixture (Herbal)

Previous Year

W. I. P. Building

Total Rs.

15,39,92,181.61

21,41,98,485.32

12,75,01,723.43

4,57,99,954.39

21,41,98,485.32

Cycle Rikchaw

18,394.00

Canteen Utensils

15,073.00

18,52,777.23

4,70,389.00

3,52,966.33

18,97,373.00

92,656.00

14,120.00

17,750.00

5,45,817.00

5,45,818.00

1,67,381.00

43,700.00

9,309.62

18,823.50

Injectable Division

28,66,296.21

6,80,541.00

13,51,678.73

5,81,181.00

5,50,163.00

11,29,594.40

84,000.00

84,342.45

9,61,322.99

3,73,935.00

8,48,358.89

38,836.00

3,30,385.92

2,83,591.24

36,544.89

Borwell

Furniture & Fixture (Shantinagar)

Furntiture & Fixture

Vehicles (Shantinagar)

Vehicles

E.P.A.B.X. (Shantinagar)

E.P.A.B.X.

Compt & Access (Shantinagar)

Computer Accessiores

Office Equipments (Shantinagar)

Office Equipments

Refrigerator

6,72,95,419.72

26,85,824.00

2,67,524.00

21,41,98,485.32

25,73,12,615.71

9,309.62

18,394.00

18,823.50

15,073.00

47,19,073.44

11,50,930.00

17,04,645.06

5,81,181.00

24,47,536.00

9,54,726.40

14,120.00

84,000.00

84,342.45

17,750.00

15,07,139.99

9,19,753.00

10,15,739.89

38,836.00

3,74,085.92

2,83,591.24

36,544.89

8,70,032.67

59,67,233.15

672.98

220.86

1,192.16

90,513.73

56,205.28

1,03,615.60

46,163.53

52,265.49

1,32,530.62

2,571.33

5,007.84

98,701.63

53,178.36

1,36,770.27

2,370.95

7,979.52

16,596.00

2,169.85

50,97,200.48

91,84,073.54

884.41

873.72

629.46

314.62

2,52,565.39

47,972.87

97,267.31

55,212.20

1,54,642.47

84,704.34

196.62

3,990.00

4,006.27

1,947.09

1,81,612.31

84,810.30

1,46,311.69

1,844.71

16,801.45

13,470.58

1,735.88

2,03,455.97

84,123.70

59,67,233.15

1,49,47,850.72

1,557.39

1,094.58

1,821.62

314.62

3,43,079.12

1,04,178.15

2,00,882.91

1,01,375.73

2,06,907.96

1,33,111.26

196.62

6,561.33

9,014.11

1,947.09

2,80,313.94

1,37,988.66

2,83,081.96

4,215.66

24,780.97

30,066.58

3,905.73

20,82,31,252.17

24,23,64,764.99

7,752.23

17,299.43

17,001.88

14,758.38

43,75,994.32

10,46,751.85

15,03,762.15

4,79,805.28

22,40,628.04

8,21,615.14

13,923.38

77,438.67

75,328.34

15,802.91

12,26,826.05

7,81,764.34

7,32,657.93

34,620.34

3,49,304.95

2,53,524.66

32,639.16

15,30,40,720.27

20,82,31,252.17

8,636.64

18,173.14

17,631.34

27,75,782.48

6,24,335.72

12,48,063.13

5,35,017.47

4,97,897.51

9,97,063.78

81,428.67

79,334.61

8,62,621.36

3,20,756.64

7,11,588.62

36,465.05

3,22,406.40

2,66,995.24

34,375.04

SCHEDULE "F" INVESTMENTS (AT COST): LONG TERM In Shares : (Unqouted) The Shamrao Vithal Co-operative Bank Ltd.

5,00,000.00

50,000.00

3,01,05,900.00

2,51,05,900.00

2,60,20,000.00

(20000 fully paid up Shares of Rs. 25 Each) (Previous Year 2,000 shares of Rs. 25 each) Of Subsidary companies Zim Laboratories Limited (30,10,590 fully paid up Shares of Rs. 10 each) (Previous Year 25,10,590 shares of Rs. 10 each) Universal Medicaments Pvt. Ltd. (8,30,000 fully paid up Shares of Rs. 10 each) GOVEREMENT SECURITIES

10,000.00

National Saving Certificates 3,06,15,900.00

5,11,75,900.00

15,57,81,907.31

11,30,41,952.29

Work-in-process.

2,42,96,039.00

1,33,99,369.00

Finished Goods.

1,13,50,248.07

4,80,63,439.00

19,14,28,194.38

17,45,04,760.29

1,28,14,872.49

78,72,109.10

51,17,01,210.44

44,01,40,942.38

52,45,16,082.93

44,80,13,051.48

SCHEDULE "G" CURRENT ASSESTS, LOANS AND ADVANCES : a) Inventories : (Valued at lower of cost or net realisable value, as certified by the management) Raw Material & Packing Materials.

(a)

b) Sundry Debtors: (Unsecured, but considered good) Exceeding six months and considered good. Others and considered good. (b)

c) Cash and Bank Balances. Cash in hand per cash book.

3,36,696.00

1,33,256.00

19,97,975.28

20,55,047.01

1,00,69,500.00

6,71,10,000.00

1,24,04,171.28

6,92,98,303.01

12,18,74,410.10

6,89,80,065.12

Balances with Excise Authorities

74,21,334.00

71,28,269.94

Deposits

75,66,090.08

53,25,064.08

Advances to suppliers.

23,54,763.03

17,75,603.31

(d)

13,92,16,597.21

8,32,09,002.45

Total (a) to (d)

86,75,65,045.80

77,50,25,117.23

Balances with Scheduled Banks. On Current Account. On Fixed Deposits. (c.) d) Loans and Advances : (Unsecured, but considered good) Advances recoverable in cash or in kind or for value to be received or pending adjustments

SCHEDULE "H" CURRENT LIABILITIES AND PROVISIONS: A. CURRENT LIABILITIES: Creditors for goods supplied Small Scale Industrial Undertaking Others.

12,99,18,798.32

33,09,58,905.89

27,00,000.00

21,39,447.00

2,45,17,170.37

5,80,53,609.98

Credit Balances (Customers)

16,68,572.00

39,75,443.20

Bank Balances (Due to reconciliation)

97,23,890.57

2,87,082.06

16,85,28,431.82

39,54,14,488.13

3,00,00,000.00

3,50,00,000.00

6,00,000.00

76,18,969.00

47,38,672.27

Total B.

3,82,18,969.00

4,03,38,672.27

Total A + B

20,67,47,400.82

43,57,53,160.40

Security Deposits Creditors for expenses and other liabilities.

Total A. B. PROVISIONS Income Tax Fringe Benefit Tax Provision for Gratuity

SCHEDULE "I" MISCELLEANOUS EXPENDITURE a) Pre-operative Expenditure

2,52,759.00

2,12,752.00

2,32,018.00

3,55,934.00

1,23,916.00

1,08,102.00

2,32,018.00

32,85,210.57

43,80,280.76

10,95,070.19

21,90,140.38

32,85,210.57

25,51,001.38

37,29,980.57

(Related to Factory at B - 34 Kalmeshwar) b) Preliminary Expenditure Less : - Written off During the Year c) Deferred Reveune Expenditure (Brand Development, R & D and Marketing Expenses) Less : - Written off During the Year

UNIJULES LIFE SCIENCES LIMITED, MUMBAI SCHEDULES FORMING PART OF PROFIT AND LOSS ACCOUNT FOR THE YEAR ENDING 31ST MARCH, 2009 2008-09

2007-08

(Rs)

1,64,43,58,987.73

1,15,94,20,073.59

2,52,747.00

4,78,275.00

1,64,46,11,734.73

1,15,98,98,348.59

57,58,372.00

4,43,089.00

Job Work Income

5,42,060.60

23,39,013.12

Miscellaneous Income

9,21,473.58

1,52,946.00

53,073.00

26,832.00

SCHEDULE "1" SALES Manufactured & Trading Goods Scrap Sales Total

SCHEDULE "2" OTHER INCOME : Interest on FDR (TDS 10,37,265/- )

Insurance Claims D.E.P.B

Foreign Exchange Flucation

7,07,911.00

2,48,968.00 -

Dividend Account

7,500.00

6,000.00

Interest Received

523.00

22,75,068.00

Profit on Sale of Fixed Assets

13,005.59

Miscellaneous Account W.Off

15,39,132.73

1,00,020.34

95,43,051.50

55,91,936.46

11,30,41,952.29

1,49,04,660.00

1,05,74,96,256.15

63,69,52,057.68

1,17,05,38,208.44

65,18,56,717.68

66,20,480.96

72,82,372.21

1,16,39,17,727.48

64,45,74,345.47

15,57,81,907.31

11,30,41,952.29

1,00,81,35,820.17

53,15,32,393.18

Total

SCHEDULE "3' COST OF MATERIALS a) Raw & Packing Material Cosumed Opening Stock Add: Purchases & Expenses Less: Sales (At Sale Price) Less: Closing Stock (a)

b) Decrease / (Increase) in Work-in-process and finished goods: Opening Stock Work- in- process

1,33,99,369.00

2,31,637.00

Finished Goods.

4,80,63,439.00

52,02,709.00

6,14,62,808.00

54,34,346.00

Work- in- process

2,42,96,039.00

1,33,99,369.00

Finished Goods.

1,13,50,248.07

4,80,63,439.00

Less: Closing Stock

3,56,46,287.07

6,14,62,808.00

2,58,16,520.93

(5,60,28,462.00)

25,53,38,525.76

42,73,13,618.06

(c.)

25,53,38,525.76

42,73,13,618.06

Total (a+b+c)

1,28,92,90,866.86

90,28,17,549.24

(b) c) Trading Goods Purchases & Expenses

SCHEDULE "4" MANUFACTURING EXPENSES Consumption of Stores

4,78,221.39

1,716.00

Water Charges

5,70,674.00

4,45,114.00

23,11,935.88

15,86,034.77

Laboratory & Analytical Expenses

26,23,950.97

21,88,604.08

Power and Electricity

41,13,213.58

35,13,194.00

Coal & Fuel

46,62,101.00

22,35,412.00

Other Manufacturing Expenses.

15,59,577.18

8,47,242.21

Research and Development Expenses

50,50,850.00

1,00,552.80

2,79,280.00

2,02,811.00

49,742.25

2,16,00,061.75

1,11,20,680.86

Wages, Salaries, Bonus and Other Payments

2,51,64,627.25

2,06,55,773.56

Contribution to Provident and Other Funds

12,99,258.00

12,69,633.00

Workmen and Staff Welfare Expenses

18,82,181.06

14,34,157.96

Remuneration to Directors

40,19,000.00

46,93,161.30

Provision for Gratuity

30,45,137.73

3,54,10,204.04

2,80,52,725.82

Repairs to : Building

2,73,116.67

Machinery

8,10,171.60

Others

12,28,647.61

State Excise Duty Excise duty on Closing Stock (Net) Total SCHEDULE "5" EMPLOYEES REMUNERATION & BENEFIT :

Total

SCHEDULE "6" OTHER EXPENSES Rent, Rates & Taxes

6,63,200.00

6,13,200.00

Insurance

7,43,037.50

4,06,752.00

1,40,224.00

1,99,552.00

81,90,550.00

14,65,109.00

1,31,25,606.20

69,25,986.44

51,95,124.09

34,75,009.46

Payment to Auditors Audit Fe

95,280.00

Tax Audit Fees

44,944.00

For Other services

Professional Charges Miscellaneous Expenses Bank Commission & Charges Travelling & Conveyance

1,45,88,125.74

90,35,019.29

Printing & Stationery

11,32,117.43

8,98,897.70

Telephone, Telex, & Postage

16,73,281.47

14,32,558.67

Cosmetic Lauching Expenses

10,54,881.18

7,75,715.34

Outward Carriage

72,59,942.64

41,70,218.30

Commission / Incentive on sales

43,85,245.85

49,15,808.41

63,08,289.90

2,44,256.00

Sales Promotion Expenses

26,84,670.17

59,47,524.37

Discount, Rate Difference and Brokerage

49,39,674.08

12,38,379.17

2,97,158.69

1,98,127.61

1,77,84,433.60

1,25,27,460.00

Liasioning Expenses

18,47,278.00

20,18,232.50

Export Sale Expenses (freight & others)

23,14,003.19

31,33,269.86

Prior Period Expenses

4,32,747.19

2,18,941.00

Late Supply Deduction

6,04,579.40

2,66,204.00

Service Tax

70,208.00

1,79,867.00

Interest (P.F., ESIC, etc. & Others)

15,625.00

3,25,492.00

4,99,407.27

224.32

25,444.00

63,768.00

9,54,50,227.64

6,12,00,199.39

Interest to Bank

4,33,21,583.00

1,34,53,548.00

Interest to Bank on Term Loan

1,40,42,077.00

1,70,43,647.00

17,56,010.00

11,38,229.00

8,36,691.00

3,59,310.00

37,103.00

1,76,710.00

44,127.00

6,01,33,071.00

3,20,75,964.00

Sales Tax Expenses Service Charges

Dubai Office Expenses Misc. A/c W/off.(Net) Exchange Gain / Loss (Net) Total SCHEDULE "7" FINANCIAL EXPENSES

Interest to Others Interest to NSIC Interest on Security Deposits Interest on Car Loan

UNIJULES LIFE SCIENCES LIMITED, MUMBAI DETAIL SHEET TO PROFIT AND LOSS ACCOUNT FOR THE YEAR ENDING 31ST MARCH, 2009 2008-09

2007-08

(Rs)

1,31,05,97,367.12

76,10,74,034.13

33,37,61,620.61

39,83,46,039.46

1,64,43,58,987.73

1,15,94,20,073.59

Raw Material Purchase

77,53,66,698.99

49,50,36,887.55

Raw Material Imported

3,99,15,243.00

76,313.90

24,23,38,079.11

13,66,52,539.42

26,09,638.80

28,72,293.75

SALES Sales of Manufacturing Goods Sales of Finished Goods Total PURCHASES AND EXPENSES :

Packing Material Purchase Inward Carriage Other Expenses

14,933.47

14,73,489.15

1,03,98,753.26

7,69,749.00

6,88,603.56

1,06,24,72,898.05

64,57,40,324.91

49,76,641.90

87,88,267.23

1,05,74,96,256.15

63,69,52,057.68

25,53,38,525.76

42,73,13,618.06

25,53,38,525.76

42,73,13,618.06

Electric Maintenance

2,40,499.99

85,936.00

Repairs others

7,74,851.12

6,51,604.39

Annual Maintenance Charges

2,13,296.50

96,000.00

12,28,647.61

8,33,540.39

Wages

38,05,848.55

37,81,843.87

Contract Wages

48,77,918.00

26,82,322.90

Salary to Managers

21,77,490.00

18,90,162.00

Salary to Others Bonus

52,95,659.00 6,68,045.00

37,18,430.05 4,13,106.27

7,27,553.00

5,89,541.08

Contract Manufacturing Purchases Commission on Purchases Less : - Cenvat Credit availed Total TRADING PURCHASES & EXPENSES Purchase of Finish Goods Total REPAIRS TO OTHERS

Total EMPYOEES COST : 1) Wages, Salaries, Bonus and other Payments

Ex. Gratia / Production Incentive

House Rent Allowances Dearness Allowances Conveyance Allowances Voluntary Retirement Scheme Gratuity Paid

32,26,241.50

25,35,973.05

9,36,124.00

15,21,874.90

25,09,547.20

20,80,983.44

6,26,316.00

13,96,692.00

9,515.00

41,895.00

Medical Allowance

13,900.00

Security Service Charges

18,513.00

Leave Travel Concession

1,00,000.00

Arrears Paid

1,71,957.00

2,949.00

2,51,64,627.25

2,06,55,773.56

12,99,258.00

12,69,633.00

12,99,258.00

12,69,633.00

17,05,230.06

11,05,369.96

948.00

2,351.00

1,76,003.00

3,26,437.00

18,82,181.06

14,34,157.96

Managing Directors Remuneration

28,74,000.00

24,00,000.00

Directors Remuneration

11,45,000.00

22,93,161.30

Total (4)

40,19,000.00

46,93,161.30

Total (1 to 4)

3,23,65,066.31

2,80,52,725.82

8,05,597.05

4,55,559.04

Children Education Allowance Total (1)

2) Contribution to Provident and Other Funds Provident Fund Total (2) 3) Workmen and staff welfare expenses Staff and Labour Welfare Labour & Welfare Fund E.S.I. Contribution Total (3) 4) Payments to Directors

Prequisties to Director

MISCELLANEOUS EXPENSES : General Expenses Legal, Registration & Tender E xpenses

25,03,106.18

26,20,561.17

Vehicle Expenses

3,62,925.97

3,43,847.41

Computer Expenses

2,00,241.00

1,92,092.00

Books and Periodicals

1,04,931.00

44,987.00

Charity and Donation

85,21,600.00

30,15,800.00

Fees and Subscription

45,142.00

78,631.32

2,500.00

33,114.00

Entertainment Expenses

1,51,956.00

Seminar Conference A/c

28,750.00

20,052.50

5,17,699.00

1,31,25,606.20

69,25,986.44

Bank Commission

26,76,703.59

5,30,662.06

Bank Guarantee Commission

10,96,508.50

8,89,342.00

Processing Charges

11,46,151.00

16,39,338.00

2,75,761.00

4,15,667.40

51,95,124.09

34,75,009.46

11,85,576.24

8,77,225.93

4,87,705.23

5,55,332.74

16,73,281.47

14,32,558.67

8,209.00

2,88,949.69

1,98,127.61

2,97,158.69

1,98,127.61

1,22,41,823.39

77,60,780.44

22,83,931.35

12,57,152.85

62,371.00

17,086.00

1,45,88,125.74

90,35,019.29

Profession Tax Festival Celebration

Rating Fees Total

BANK COMMISSION & OTHER CHARGES

Bank Commission on LC

TELEPHONE, AND POSTAGE EXPENES : Telephone Postage Total

SALES TAX Surcharge on BST Sales Tax paid Vat Set Off Disallowed Total

TRAVELLING AND CONVEYANCE Travelling Conveyance Toll Tax Exp enses

CONSUMABLE STORES: Stores and spares Purchased Tools and Dies Purchased

478,221.39 -

478,221.39

65,96,270.00

Education Cess Paid

73,873.00

S.H. Education Cess Paid

36,880.00

67,07,023.00

Excise Duty Basic Excise Duty

Ali Hatim S. Husain Chartered Accountant Membership No. 113999 Nagpur Dated the, 12th June 2009

Faiz Vali (Chief Executive Officer)

D. K. Bellani (Chief Production Officer)

UNIJULES LIFE SCIENCES LIMITED ACCOUNTING POLICIES & NOTES ON ACCOUNTS Schedule â&#x20AC;&#x153;J" A. Significant Accounting Policies 1. General: The accounts are prepared on the historical cost convention and in accordance with the requirement of Companies Act, 1956. Accounting Policies not specifically referred to otherwise are consistent and in consonance with generally accepted accounting principles. 2. Revenue Recognition: Expenses and Income considered payable and receivable respectively are accounted for on accrual. 3. Fixed Assets: Fixed assets are stated at their original cost of acquisition ( net of tax / duty credit availed ) including freight and other incidental expenses related to acquisition and installation of the concerned assets less depreciation till date. 4. Depreciation on Fixed Assets: Depreciation on Fixed Assets has been provided on straight-line method, on the cost of Fixed Assets as per the rates, provided in Schedule XIV of the Companies Act, 1956. 5. Investments: Investments are stated at cost. 6. Inventories: Inventories are valued at cost or net realizable value, whichever is lower. Cost is determined on the basis of the first in first out and includes all cost incurred in bringing the inventories to their present location and condition. 7. Miscellaneous Expenditure: Preliminary expenses have been amortised over a period of five years. 8. Retirement Benefits: The liabilities towards retirement benefits are accounted for in according with AS-15. 9. Foreign Currency Transactions: All receivables and payables at the year-end invoiced in foreign currencies in respect of imports and export made, for which no forward cover has been taken, are accounted for at the appropriate respective year-end exchange rates.

10. Taxes on Income: Provision for current tax is made on the basis of estimated taxable income for the current accounting year in accordance with the Income Tax Act, 1961. The deferred tax for timing differences between the book and tax profits for the year is accounted for, using the tax rates and laws that have been substantively enacted as on the balance sheet date.

B. Notes on Accounts 1. Sundry Creditors, Sundry Debtors, Loans & Advances have been taken at their book value subject to confirmation and reconciliation. 2.

Payment to Auditors

Auditors Remuneration

2008-09 (Rs.)

2007-08 (Rs.)

Audit Fees & Tax Audit Fee

1,60,000/-

19,770/-

1,60,000/-

1,79,770/-

2008-09 (Rs.) 40,19,000.00 40,19,000.00

2007-08 (Rs.) 46,93,161.30 46,93,161.30

Service Tax Total

3. Payment to Director Directors Remuneration Salary & Bonus Sitting fees Total

4. Loans and Advances are considered good in respect of which company does not hold any security other than the personal guarantee of persons. 5. Loans and advances includes amount outstanding from directors or/and Company in which directors are interested. Maximum Balance during the year: 2008-09 Max. Bal. (Rs.) 0 0 0 0 0 0 1,94,85,250/2,06, 85,250/0 0 81,051.50 1,35,302.50 2,12,29,938.75 2,12,29,938.75 0 24,91,644.41 5,06,055/59,02,713/4,12,21,243.75 5,03,09,546.16

Closing Balance(Rs.) Zim Laboratories Limited City Pharmacy Akasa Advertisement Faiz Vali D.K. Bellani I.A. Trivedi Universal Medicaments Pvt. Ltd. Universal Pharmacy Saif Health Remedies Pvt. Ltd. Total

2007-08 Closing Max. Bal. Balance(Rs.) (Rs.) 1,33,633/6,45,128/16,75,453/1675,453/8,18,225/8,18,225/16,44,662/16,44,662/62563.50 62563.50 34,571/41,528/0 0 0 0 59,02,713/1,09,02,713/-

6. Additional information pursuit to provision of paragraph 3 and 4 of part II of the schedule VI of the companies Act, 1956 is Nil or none except given below. (a) Quantitative Details of Opening Stock Turnover, Production/Purchases, Closing Stock

C) PRODUCTION QUANTITY Unit

31/03/2009

31/03/2008

Allopathic : Liquid

Ltrs

13,15,866

2,22,951

Ointment

Kgs.

36,603

47,238

Powder

Kgs.

1,045

Capsulses ('000)

Nos.

6,517

2,33,642

Nos

5,03,94,729

Liquid

Ltrs

78,188

Tablets ('000)

Nos.

52,380

Capsulses ('000)

Nos.

87,858

Powder

Kgs.

17,37,814

Ointment

Kgs.

Injection : Vials/ Ampoules Herbal :

Job Work : Liquid

Ltrs

1,35,500

Ointment

Kgs.

Tablets ('000)

Nos.

Capsulses ('000)

Nos.

Vials/ Ampoules

Nos.

1,57,000

21,775 15,438

D [1]) Opening Stock of Finished Goods: 31-03-2009 Quantity Allopathic : Liquid in Ltrs Ointment in Kgs. Powder in Kgs. Capsules in ('000)

31-03-2008 Value

31.03.09 15,249

12,70,500

1,077

3,00,980

2,860

3,496

2,37,342

9,009

169

Liquid in Ltrs.

Tablets in ('000)

Capsules in ('000)

Powder in Kgs.

Ointment in Kgs.

3,08,184 -

Injection 7,46,813

45,02,752

Trading Stock: Tablets in ('000)

Value

31.03.08

Herbal :

Vials / Ampoules

Quantity

436

2,92,524

Capsules in ('000)

1,550

10,65,279

Liquid in Ltrs

3,211

3,06,264

Absorbent Cotton

Bandage Cloth

Band Aid Strips

Eye Drop Powder A.P.I.

903 28,350 8,01,107

5,030 3,97,62,546 4,80,63,438

D [2]) Closing Stock of Finished Goods : 31-03-2009

31-03-2008

Quantity

Value

Quantity

Value

20,042

32,58,463

14,600

12,14,633

654

1,25,615

899

2,03,300

Powder in Kgs.

Capsules in ('000)

7,590

3,496

2,37,342

2,319

2,29,655

Tablets in ('000)

718

1,46,199

Capsules in ('000)

283

1,41,061

Powder in Kgs.

348

1,77,458

5,07,89,589

55,73,601

5,32,800

Trading Stock:

Tablets in ('000)

1,281

11,96,334

436

2,92,524

Capsules in ('000)

178

1,39,652

1,550

13,80,552

Liquid in Ltrs

156

3,53,949

3,211

3,06,264

672

Eye Drop

5,030

A.P.I.

28,350

3,97,62,546

5,08,15,590

1,13,50,249

52,628

4,39,34,990

Allopathic : Liquid in Ltrs Ointment in Kgs.

Herbal : Liquid in Ltrs.

Injection : Vials/ Ampoules

Absorbent Cotton

E) Purchase of Finished Goods and Trading Good s: 2008-09

2007-08

Unit

Quantity

Tablets in ('000)

Nos

9532.37

8,112

Capsules in ('000)

Nos

6035.17

4,457

Liquid in Ltrs

Ltr

9630.31

3,806

Absorbent Cotton

Mtr

1100

Vial & Ampoulses

Nos

430600

Band Aid Strips

Kgs

Eye Drop

Nos

1162.2

Powder

Kgs

F) A.I.P.

Kgs

64 28,350

F) TURNOVER: Class of Goods

2008-09

2007-08

Unit

Quantity

1) Liquid

Ltrs

1311072.84

2,08,351

2) Ointment

Kgs

37025.19

46,339

3) Powder

Kgs

1056.24

4) Capsules ('000)

Nos

10005

1) Liquid

Ltr

75878.88

2) Tablets ('000)

Nos

51661.5

3) Capsulses ('000)

Nos

87575.12

4) Powder

Kgs

1737467.04

5) Ointment

Kgs

Allopathic:

2,30,146

Herbal

Injection : 1) Vials/ Ampoules

351864 Nos

89.52

Tablets in ('000)

Nos

8687.19

7,676

Capsules in ('000)

Nos

7407.33

2,907

Liquid in Ltrs

Ltr

12685.58

595

Absorbent Cotton

Mtr

1086

Vials & Ampoulses

Nos

430600

Trading Goods :

Band Aid Strips

Kgs

Eye Drop

Nos

2065.23

Powder

Kgs

A.I.P.

Kgs

28350

(b) Consumption of consumables and raw material have been arrived by adding purchases to opening stock and deducted closing stock there from. Raw Material Consumption Sr. No. 1 2 3 4 5 6 7 8 9 10 11

Items

Unit

Quinine Di-Hydrochloride Shuddha Guggul Alpha-Beta Arteether Diatrizoic Acid Chandan White Kajjali Kalimirch Atees Bottles in Lacs Amber Ampoules in Lacs Miscellaneous (None of Which individually account for more than 10 % of total consumption) To tal

Kgs Kgs Kgs Kgs Kgs Kgs Kgs Kgs Nos Nos

Qty 24065.200 2,14,794.720 2449.944 19182.120 6,302.000 83,851.000 1,25,236.300 26,127.000 85.027 276.672

Amt. 13,44,14,634.40 8,32,25,944.54 5,45,31,811.00 4,81,06,986.10 2,95,56,380.00 2,41,60,603.73 2,39,09,489.87 2,22,08,007.80 2,11,90,663.74 2,07,50,403.25 46,20,54,924.43

100,81,35,820.17

A% of imported & indigenous raw material & consumables 2008-09 % Imported Indigenous

Amount

2.96 97.04

3,12,93,744.00 102,62,02,512.15

7. Major components of Deferred tax Particulars

As at 31.03.2009 (Rs.)

A) Deferred Tax Liabilities Depreciation Total B) Deferred Tax Assets Disallowance u/s 40(a)(ia) Disallowance U/s 43B Total Net Deferred Tax liabilities/(assets) (A -B)

2,22,58,322.13 2,22,58,322.13 1,04,427.77 2,16,640.02 3,20,667.79 2,19,34,254.33

8. Contingent Liabilities Comfort Letter given by the company for the loan taken by Zim Laboratories Limited from Shamrao Vithal Co-operative Bank Ltd. And The Axis Bank Ltd., Nagpur for Rs. 25.00 Cr. of working capital and for Rs. 7.79 Cr. Term loan.

9. Related Party Disclosure

Sr.No. 1 2 3 4 5 6 7 8 9 10 11 12

Name of the related party Zim Laboratories Limited Akasa Advertising Universal Medicaments Pvt. Ltd. Faiz Vali D. K. Bellani I.A.Trivedi Anwar Daud Universal Pharmacy Universal Ayurvaid City Pharmacy Esa M. Vali Tasneem Daud

Relationship with the company Subsidiary Company Relative of Director is a partner Director is Interested Director of the company Director of the company Director of the company Director of the company Relative of director is a partner Relative of director is a partner Director is a partner Relative of Director Relative of Director

Transaction with Related Parties Particular

Amount

Construction Material Purchased

2,25,739.00

Sales of RM / PM / FG

3,30,09,008.20

Purchase of RM/ PM FG

1,78,86,448.80

Professional Charges received

8,00,000.00

Sales of Fixed Assets

30,60,260.00